Streetbeat News

Analyst Ratings

FMS

Truist Securities has maintained a Hold rating on Fresenius Medical Care (NYSE:FMS) while raising the price target from $22 to $23.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:31 pm

DVA

Truist Securities has maintained a Hold rating on DaVita (NYSE:DVA) while raising the price target from $165 to $175, indicating a positive outlook on the stock's potential performance.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:30 pm

DGX

Truist Securities has maintained a Hold rating on Quest Diagnostics while raising the price target from $158 to $165.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:29 pm

APD

Evercore ISI Group has upgraded Air Products & Chemicals (NYSE:APD) from In-Line to Outperform, raising the price target from $305 to $365.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:22 pm

AAPL

CHSN

EVO

HRTG

MBLY

SCL

SHW

SIFY

Several major stocks, including Sherwin-Williams and Apple, are experiencing declines in Monday's pre-market session. Sherwin-Williams was downgraded by Keybanc, leading to a 1.4% drop. Other stocks like Chanson International and Heritage Insurance also saw significant pre-market losses.

Portfolio Pulse from Avi Kapoor

October 07, 2024 | 12:22 pm

OHI

BMO Capital has maintained a Market Perform rating on Omega Healthcare Investors (NYSE:OHI) and raised its price target from $44 to $45.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:20 pm

CTRE

BMO Capital has maintained an 'Outperform' rating on CareTrust REIT and raised its price target from $33 to $34, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:18 pm

CC

BMO Capital analyst John McNulty maintains an Outperform rating on Chemours (NYSE:CC) and raises the price target from $30 to $32.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:15 pm

CE

CRL

HSY

NFLX

STZ

Several top Wall Street analysts have downgraded their ratings for major companies, including Netflix, Hershey, Celanese, Constellation Brands, and Charles River Laboratories. These downgrades may impact the short-term stock performance of these companies.

Portfolio Pulse from Avi Kapoor

October 07, 2024 | 12:03 pm

UROY

B. Riley Securities has initiated coverage on Uranium Royalty (NASDAQ:UROY) with a Buy rating and set a price target of $3.5.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:02 pm